Singapore markets open in 3 hours 25 minutes
AIRLINES

Omicron’s rapid spread shreds budding recovery in air travel

Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (T14.SI)

SES - SES Delayed Price. Currency in USD
Add to watchlist
1.0500-0.0200 (-1.87%)
At close: 05:09PM SGT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
6,998,847
6,603,652
6,993,882
6,358,622
5,689,242
Cost of revenue
4,149,281
4,027,755
4,046,928
3,722,834
3,480,047
Gross profit
2,849,566
2,575,897
2,946,953
2,635,789
2,209,195
Operating expenses
Research development
168,304
149,202
133,361
100,925
79,426
Selling general and administrative
1,618,147
1,541,679
1,914,801
1,760,449
1,488,377
Total operating expenses
2,095,420
1,979,962
2,380,869
2,159,627
1,851,913
Operating income or loss
754,146
595,934
566,084
476,162
357,282
Interest expense
-
6.66
4,893
11,382
9,541
Income before tax
967,696
768,058
743,145
640,629
531,001
Income tax expense
104,421
88,396
107,786
72,841
57,740
Income from continuing operations
863,275
679,662
635,359
567,788
473,261
Net income
846,414
661,704
625,569
561,680
476,080
Net income available to common shareholders
846,414
661,704
625,569
561,680
476,080
Basic EPS
-
0.86
0.81
0.73
0.62
Diluted EPS
-
0.86
0.81
0.73
0.62
Basic average shares
-
769,424
772,307
769,424
767,871
Diluted average shares
-
769,424
772,307
769,424
767,871
EBITDA
-
878,913
846,187
728,159
613,336